These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 25223345)
1. Epidermal growth factor receptor expression in canine transitional cell carcinoma. Hanazono K; Fukumoto S; Kawamura Y; Endo Y; Kadosawa T; Iwano H; Uchide T J Vet Med Sci; 2015 Jan; 77(1):1-6. PubMed ID: 25223345 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of p63, Ki67 and β-catenin in canine transitional cell carcinoma and polypoid cystitis of the urinary bladder. Hanazono K; Nishimori T; Fukumoto S; Kawamura Y; Endo Y; Kadosawa T; Uchide T Vet Comp Oncol; 2016 Sep; 14(3):263-9. PubMed ID: 24758385 [TBL] [Abstract][Full Text] [Related]
3. Identification of survivin, an inhibitor of apoptosis, in canine urinary bladder transitional cell carcinoma. Rankin WV; Henry CJ; Turnquist SE; Turk JR; Beissenherz ME; Tyler JW; Rucker EB; Knapp DW; Rodriguez CO; Green JA Vet Comp Oncol; 2008 Sep; 6(3):141-50. PubMed ID: 19178674 [TBL] [Abstract][Full Text] [Related]
4. Expression of microRNAs in urinary bladder samples obtained from dogs with grossly normal bladders, inflammatory bladder disease, or transitional cell carcinoma. Vinall RL; Kent MS; deVere White RW Am J Vet Res; 2012 Oct; 73(10):1626-33. PubMed ID: 23013190 [TBL] [Abstract][Full Text] [Related]
5. Comparison of distributions of survivin among tissues from urinary bladders of dogs with cystitis, transitional cell carcinoma, or histologically normal urinary bladders. Rankin WV; Henry CJ; Turnquist SE; Turk JR; Beissenherz ME; Tyler JW; Green JA Am J Vet Res; 2008 Aug; 69(8):1073-8. PubMed ID: 18672973 [TBL] [Abstract][Full Text] [Related]
6. Prognostic role of ΔNp63 expression in canine transitional cell carcinoma of the urinary bladder. Nishimori T; Hanazono K; Matsuda K; Kawamura Y; Kadosawa T; Endo Y; Uchide T Open Vet J; 2021; 11(4):700-706. PubMed ID: 35070867 [TBL] [Abstract][Full Text] [Related]
7. Expression of receptor tyrosine kinase targets PDGFR-β, VEGFR2 and KIT in canine transitional cell carcinoma. Walters L; Martin O; Price J; Sula MM Vet Comp Oncol; 2018 Mar; 16(1):E117-E122. PubMed ID: 28884928 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA profiling of dogs with transitional cell carcinoma of the bladder using blood and urine samples. Kent MS; Zwingenberger A; Westropp JL; Barrett LE; Durbin-Johnson BP; Ghosh P; Vinall RL BMC Vet Res; 2017 Nov; 13(1):339. PubMed ID: 29141625 [TBL] [Abstract][Full Text] [Related]
9. SiRNA knockdown of the DEK nuclear protein mRNA enhances apoptosis and chemosensitivity of canine transitional cell carcinoma cells. Yamazaki H; Iwano T; Otsuka S; Kagawa Y; Hoshino Y; Hosoya K; Okumura M; Takagi S Vet J; 2015 Apr; 204(1):60-5. PubMed ID: 25773167 [TBL] [Abstract][Full Text] [Related]
10. Lipoxygenase-5 Expression in Canine Urinary Bladder: Normal Urothelium, Cystitis and Transitional Cell Carcinoma. Finotello R; Schiavo L; Ressel L; Frohmader A; Silvestrini P; Verin R J Comp Pathol; 2019 Jul; 170():1-9. PubMed ID: 31375151 [TBL] [Abstract][Full Text] [Related]
11. Assessment of HER2 Expression in Canine Urothelial Carcinoma of the Urinary Bladder. Tsuboi M; Sakai K; Maeda S; Chambers JK; Yonezawa T; Matsuki N; Uchida K; Nakayama H Vet Pathol; 2019 May; 56(3):369-376. PubMed ID: 30612533 [TBL] [Abstract][Full Text] [Related]
12. Expression of cell cycle regulators, 14-3-3σ and p53 proteins, and vimentin in canine transitional cell carcinoma of the urinary bladder. Suárez-Bonnet A; Herráez P; Aguirre M; Suárez-Bonnet E; Andrada M; Rodríguez F; Espinosa de Los Monteros A Urol Oncol; 2015 Jul; 33(7):332.e1-7. PubMed ID: 25979650 [TBL] [Abstract][Full Text] [Related]
13. Identifying the ErbB/MAPK Signaling Cascade as a Therapeutic Target in Canine Bladder Cancer. Cronise KE; Hernandez BG; Gustafson DL; Duval DL Mol Pharmacol; 2019 Jul; 96(1):36-46. PubMed ID: 31048548 [TBL] [Abstract][Full Text] [Related]
14. Ultrasound characteristics of feline urinary bladder transitional cell carcinoma are similar to canine urinary bladder transitional cell carcinoma. Hamlin AN; Chadwick LE; Fox-Alvarez SA; Hostnik ET Vet Radiol Ultrasound; 2019 Sep; 60(5):552-559. PubMed ID: 31144408 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of HER-2 via immunohistochemistry in canine urinary bladder transitional cell carcinoma - A marker of malignancy and possible therapeutic target. Millanta F; Impellizeri J; McSherry L; Rocchigiani G; Aurisicchio L; Lubas G Vet Comp Oncol; 2018 Jun; 16(2):297-300. PubMed ID: 28871659 [TBL] [Abstract][Full Text] [Related]
16. Anti-tumour effect of lapatinib in canine transitional cell carcinoma cell lines. Sakai K; Maeda S; Saeki K; Nakagawa T; Murakami M; Endo Y; Yonezawa T; Kadosawa T; Mori T; Nishimura R; Matsuki N Vet Comp Oncol; 2018 Dec; 16(4):642-649. PubMed ID: 30246405 [TBL] [Abstract][Full Text] [Related]
17. Management of transitional cell carcinoma of the urinary bladder in dogs: a review. Fulkerson CM; Knapp DW Vet J; 2015 Aug; 205(2):217-25. PubMed ID: 25747698 [TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of an oncolytic measles virus against canine urinary bladder transitional cell carcinoma cells. Iizuka K; Shoji K; Fujiyuki T; Moritoh K; Tamura K; Yoshida A; Sato H; Yoneda M; Asano K; Kai C Res Vet Sci; 2020 Dec; 133():313-317. PubMed ID: 33183781 [TBL] [Abstract][Full Text] [Related]
19. Hedgehog signaling is activated in canine transitional cell carcinoma and contributes to cell proliferation and survival. Gustafson TL; Kitchell BE; Biller B Vet Comp Oncol; 2017 Mar; 15(1):174-183. PubMed ID: 25864514 [TBL] [Abstract][Full Text] [Related]
20. Gene expression of prostaglandin EP4 receptor in three canine carcinomas. Musser ML; Viall AK; Phillips RL; Hostetter JM; Johannes CM BMC Vet Res; 2020 Jun; 16(1):213. PubMed ID: 32571310 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]